Back to search

Article

Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma

2022-06-16

Abstract excerpt

Temozolomide (TMZ) resistance is a major clinical challenge for glioblastoma (GBM). O 6 -methylguanine-DNA methyltransferase (MGMT) mediated DNA damage repair is a key mechanism for TMZ resistance. However, MGMT-null GBM patients remain resistant to TMZ, and the process for resistance evolution is largely unknown. Here, we developed an acquired TMZ resistant xenograft model using serial implantation of MGMT-null U...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d6d4182a-6b85-5101-bbbd-ff5bfc118a71
DOI
10.21203/rs.3.rs-1700654/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Characterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastomaDOI 10.21203/rs.3.rs-1700654/v1
Select a neighboring publication to make it the new centre.